{"transactions":[{"id":743395,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T21:52:18.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":15200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":15200,"derivative":{"exercise_price":35.21,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":15200},"source":{"system":"sec-edgar","filing":"0001193125-26-266147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000119312526266147/ownership.xml","form_type":"4"}},{"id":1106592,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:15:12.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":10925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest upon the earlier of (i) June 17, 2026 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":10925,"derivative":{"exercise_price":10.95,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":10925},"source":{"system":"sec-edgar","filing":"0000950170-25-087900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000095017025087900/ownership.xml","form_type":"4"}},{"id":1373105,"issuer":{"id":4394,"kind":"organization","name":"Rapport Therapeutics, Inc.","symbol":"RAPP"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-08T00:00:11.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":29756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying this option shall vest and become exercisable on November 7, 2025, with the remaining shares vesting in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":29756,"derivative":{"exercise_price":26.9,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":29756},"source":{"system":"sec-edgar","filing":"0000950170-24-123610","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012593/000095017024123610/ownership.xml","form_type":"4"}},{"id":1879800,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-24T18:44:55.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":12054,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12054,"derivative":{"exercise_price":25.74,"exercise_date":"2024-05-22","expiration_date":"2033-05-21","underlying":"Common Stock","underlying_shares":12054},"source":{"system":"sec-edgar","filing":"0001209191-23-031850","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123031850/doc4.xml","form_type":"4"}},{"id":1879799,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T18:44:55.000Z","date":"2023-05-22","kind":"grant","planned":false,"acquired":true,"shares":6027,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15806,"source":{"system":"sec-edgar","filing":"0001209191-23-031850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919123031850/doc4.xml","form_type":"4"}},{"id":1963674,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-08T17:06:06.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":13667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a 8-month period: 1/8th on October 26, 2022, after which 1/8th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":13667,"derivative":{"exercise_price":4.2,"expiration_date":"2032-10-25","underlying":"Common Stock","underlying_shares":13667},"source":{"system":"sec-edgar","filing":"0001209191-23-017244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123017244/doc4.xml","form_type":"4"}},{"id":1963673,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-08T17:06:06.000Z","date":"2023-03-06","kind":"disposition_to_issuer","acquired":false,"shares":13667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests over a 8-month period: 1/8th on October 26, 2022, after which 1/8th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":17.83,"expiration_date":"2032-10-25","underlying":"Common Stock","underlying_shares":13667},"source":{"system":"sec-edgar","filing":"0001209191-23-017244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919123017244/doc4.xml","form_type":"4"}},{"id":2131151,"issuer":{"id":76517,"kind":"organization","name":"Third Harmonic Bio, Inc.","symbol":"THRD"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-27T16:58:56.000Z","date":"2022-10-26","kind":"grant","acquired":true,"shares":13667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 8-month period: 1/8th on October 26, 2022, after which 1/8th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":13667,"derivative":{"exercise_price":17.83,"expiration_date":"2032-10-25","underlying":"Common Stock","underlying_shares":13667},"source":{"system":"sec-edgar","filing":"0001209191-22-054730","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1923840/000120919122054730/doc4.xml","form_type":"4"}},{"id":2256813,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-25T21:53:48.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":12810,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12810,"derivative":{"exercise_price":24.14,"exercise_date":"2023-05-23","expiration_date":"2032-05-22","underlying":"Common Stock","underlying_shares":12810},"source":{"system":"sec-edgar","filing":"0001209191-22-031951","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122031951/doc4.xml","form_type":"4"}},{"id":2256812,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T21:53:48.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":6405,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9779,"source":{"system":"sec-edgar","filing":"0001209191-22-031951","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919122031951/doc4.xml","form_type":"4"}},{"id":2697041,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-25T20:46:45.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":6748,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6748,"derivative":{"exercise_price":45.28,"exercise_date":"2022-05-21","expiration_date":"2031-05-20","underlying":"Common Stock","underlying_shares":6748},"source":{"system":"sec-edgar","filing":"0001209191-21-035713","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121035713/doc4.xml","form_type":"4"}},{"id":2697040,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-25T20:46:45.000Z","date":"2021-05-21","kind":"grant","acquired":true,"shares":3374,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3374,"source":{"system":"sec-edgar","filing":"0001209191-21-035713","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919121035713/doc4.xml","form_type":"4"}},{"id":3008348,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-13T23:12:44.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":24567,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24567,"derivative":{"exercise_price":37.06,"exercise_date":"2021-05-21","expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":24567},"source":{"system":"sec-edgar","filing":"0001209191-20-054739","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120054739/doc4a.xml","form_type":"4/A","original_submission_date":"2020-05-26"}},{"id":3135250,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-26T21:00:18.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":28888,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28888,"derivative":{"exercise_price":37.06,"exercise_date":"2021-05-21","expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":28888},"source":{"system":"sec-edgar","filing":"0001209191-20-032060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919120032060/doc4.xml","form_type":"4"}},{"id":3338592,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-12-17T21:50:25.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark restricted stock unit, whether vested or unvested, was canceled and converted into the right to receive $114.50 in cash (less applicable tax withholdings)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark restricted stock unit, whether vested or unvested, was canceled and converted into the right to receive $114.50 in cash (less applicable tax withholdings)."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000899243-19-029446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924319029446/doc4.xml","form_type":"4"}},{"id":3338591,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:50:25.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."}],"balance_after":0,"derivative":{"exercise_price":55.76,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000899243-19-029446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924319029446/doc4.xml","form_type":"4"}},{"id":3338590,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-17T21:50:25.000Z","date":"2019-12-17","kind":"disposition_to_issuer","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, each outstanding Spark stock option, whether vested or unvested, was converted into the right to an amount in cash (less applicable tax withholdings) equal to the product of (a) the excess of $114.50 over the per share exercise price of such stock option and (b) the total number of shares of common stock subject to such stock option."}],"balance_after":0,"derivative":{"exercise_price":81.53,"expiration_date":"2028-05-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000899243-19-029446","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924319029446/doc4.xml","form_type":"4"}},{"id":3338589,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-17T21:50:25.000Z","date":"2019-12-17","kind":"other","acquired":false,"shares":2500,"price":114.5,"value":286250.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated February 22, 2019, by and between Spark Therapeutics, Inc. (\"Spark\"), Roche Holdings, Inc. (\"Roche\") and 022019 Merger Subsidiary, Inc. (\"Merger Sub\") (the \"Merger Agreement\" and the transactions contemplated thereby, the \"Merger\"), whereby Roche caused Merger Sub to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.001 per share, of Spark, at a price of $114.50 per share. On December 17, 2019, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-19-029446","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924319029446/doc4.xml","form_type":"4"}},{"id":3394755,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-10T23:17:02.000Z","date":"2019-10-10","kind":"grant","acquired":true,"shares":22222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares subject to the stock option vest and become exercisable on October [10], 2020, and the remainder vest in 24 equal monthly installments thereafter."}],"balance_after":22222,"derivative":{"exercise_price":20,"expiration_date":"2029-10-10","underlying":"Common Stock","underlying_shares":22222},"source":{"system":"sec-edgar","filing":"0001209191-19-052974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000120919119052974/doc4.xml","form_type":"4"}},{"id":3476809,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-27T23:36:40.000Z","date":"2019-06-26","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 26, 2020 or the date of the 2020 annual meeting of stockholders, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company."}],"balance_after":27000,"derivative":{"exercise_price":1.25,"expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000899243-19-018481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924319018481/doc4.xml","form_type":"4"}},{"id":3485943,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-18T20:25:37.000Z","date":"2019-06-14","kind":"grant","acquired":true,"shares":7131,"price":1.6654,"value":11875.9674,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":7131,"derivative":{"exercise_price":2.43,"expiration_date":"2029-06-14","underlying":"Common Stock","underlying_shares":7131},"source":{"system":"sec-edgar","filing":"0001209191-19-037689","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000120919119037689/doc4.xml","form_type":"4"}},{"id":3504460,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-03T20:18:28.000Z","date":"2019-05-30","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 30, 2018, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date.  Vested shares are delivered to the reporting person on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 30, 2018, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date.  Vested shares are delivered to the reporting person on the vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001609351-19-000058","document":"wf-form4_155959308804475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000160935119000058/wf-form4_155959308804475.xml","form_type":"4"}},{"id":3504459,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-03T20:18:28.000Z","date":"2019-05-30","kind":"exercise","acquired":true,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001609351-19-000058","document":"wf-form4_155959308804475.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000160935119000058/wf-form4_155959308804475.xml","form_type":"4"}},{"id":3519546,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-20T07:33:08.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":17326,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's 2019 annual meeting of stockholders."}],"balance_after":17326,"derivative":{"exercise_price":10.78,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":17326},"source":{"system":"sec-edgar","filing":"0000792977-19-000107","document":"wf-form4_155835197338660.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000107/wf-form4_155835197338660.xml","form_type":"4"}},{"id":3519545,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-20T07:33:08.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":8116,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's 2019 Equity Incentive Plan (the \"Plan\") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's 2019 annual meeting of stockholders; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":29229,"source":{"system":"sec-edgar","filing":"0000792977-19-000107","document":"wf-form4_155835197338660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297719000107/wf-form4_155835197338660.xml","form_type":"4"}},{"id":3564208,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-03T20:29:02.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":4369,"price":2.7185,"value":11877.1265,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":4369,"derivative":{"exercise_price":4.4,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":4369},"source":{"system":"sec-edgar","filing":"0001209191-19-023130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000120919119023130/doc4.xml","form_type":"4"}},{"id":3685255,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-29T00:01:06.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":5717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2019 on a quarterly basis in arrears."}],"balance_after":5717,"derivative":{"exercise_price":4.38,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":5717},"source":{"system":"sec-edgar","filing":"0000899243-19-002064","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924319002064/doc4.xml","form_type":"4"}},{"id":3685254,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-29T00:01:06.000Z","date":"2019-01-24","kind":"grant","acquired":true,"shares":4423,"price":4.38,"value":19372.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The common stock was acquired in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Unit Award and the restrictions lapse over a period of one year starting January 1, 2019 on a quarterly basis in arrears. Each restricted stock unit represents a contingent right to receive one share of Zafgen, Inc. common stock."}],"balance_after":5322,"source":{"system":"sec-edgar","filing":"0000899243-19-002064","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924319002064/doc4.xml","form_type":"4"}},{"id":3703580,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T21:55:54.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":4397,"price":2.7,"value":11871.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":4397,"derivative":{"exercise_price":4.47,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":4397},"source":{"system":"sec-edgar","filing":"0001209191-19-002045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000120919119002045/doc4.xml","form_type":"4"}},{"id":3703579,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-01-04T21:04:23.000Z","date":"2019-01-03","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 3, 2018, the reporting person was granted 3,000 restricted stock units that vest in three equal annual installments beginning January 3, 2019. Vested shares will be delivered to the reporting person annually on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On January 3, 2018, the reporting person was granted 3,000 restricted stock units that vest in three equal annual installments beginning January 3, 2019. Vested shares will be delivered to the reporting person annually on the vesting date."}],"balance_after":2000,"derivative":{"underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001609351-19-000004","document":"wf-form4_154663584200619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000160935119000004/wf-form4_154663584200619.xml","form_type":"4"}},{"id":3703578,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T21:04:23.000Z","date":"2019-01-03","kind":"exercise","acquired":true,"shares":1000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001609351-19-000004","document":"wf-form4_154663584200619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000160935119000004/wf-form4_154663584200619.xml","form_type":"4"}},{"id":3798282,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T21:16:11.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":1910,"price":6.22,"value":11880.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":1910,"derivative":{"exercise_price":10.37,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":1910},"source":{"system":"sec-edgar","filing":"0001209191-18-053967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000120919118053967/doc4.xml","form_type":"4"}},{"id":3807146,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-26T22:46:03.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":1361,"price":8.72,"value":11867.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested at time of grant."}],"balance_after":1361,"derivative":{"exercise_price":14.57,"expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":1361},"source":{"system":"sec-edgar","filing":"0001209191-18-052363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000120919118052363/doc4.xml","form_type":"4"}},{"id":3900927,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T16:11:05.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":7543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders."}],"balance_after":7543,"derivative":{"exercise_price":24.45,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":7543},"source":{"system":"sec-edgar","filing":"0000792977-18-000041","document":"wf-form4_152848864906632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297718000041/wf-form4_152848864906632.xml","form_type":"4"}},{"id":3900926,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T16:11:05.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":3578,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the \"Plan\") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders, however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":21113,"source":{"system":"sec-edgar","filing":"0000792977-18-000041","document":"wf-form4_152848864906632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000079297718000041/wf-form4_152848864906632.xml","form_type":"4"}},{"id":3901397,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-07T21:33:11.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 6, 2019 or the date of the 2019 annual meeting of stockholders, subject to the director's continued service on the board of directors, provided that, all shares shall become fully vested upon a change in control of the Company."}],"balance_after":20000,"derivative":{"exercise_price":6.79,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-18-015550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924318015550/doc4.xml","form_type":"4"}},{"id":3910506,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-01T12:48:29.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units vest on the one-year anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units vest on the one-year anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001609351-18-000061","document":"wf-form4_152785725185875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000160935118000061/wf-form4_152785725185875.xml","form_type":"4"}},{"id":3910505,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-01T12:48:29.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares vest on the one-year anniversary of the grant date."}],"balance_after":4000,"derivative":{"exercise_price":81.53,"expiration_date":"2028-05-29","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001609351-18-000061","document":"wf-form4_152785725185875.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000160935118000061/wf-form4_152785725185875.xml","form_type":"4"}},{"id":4105265,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-05T21:59:12.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":9421,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2018 on a quarterly basis in arrears."}],"balance_after":9421,"derivative":{"exercise_price":5.18,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":9421},"source":{"system":"sec-edgar","filing":"0000899243-18-000591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924318000591/doc4.xml","form_type":"4"}},{"id":4107179,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-01-04T22:22:36.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutic common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning January 3, 2019.  Vested shares will be delivered to the reporting person annually on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning January 3, 2019.  Vested shares will be delivered to the reporting person annually on the vesting date."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001609351-18-000006","document":"wf-form4_151510454329592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000160935118000006/wf-form4_151510454329592.xml","form_type":"4"}},{"id":4107178,"issuer":{"id":153045,"kind":"organization","name":"Spark Therapeutics, Inc.","symbol":"ONCE"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T22:22:36.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% vests January 3, 2019 and the remainder vests in equal annual installments over the following two years."}],"balance_after":8000,"derivative":{"exercise_price":55.76,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001609351-18-000006","document":"wf-form4_151510454329592.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000160935118000006/wf-form4_151510454329592.xml","form_type":"4"}},{"id":4249961,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-27T12:57:58.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017."}],"balance_after":12000,"derivative":{"exercise_price":4.08,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001615219-17-000059","document":"wf-form4_150116026485727.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000161521917000059/wf-form4_150116026485727.xml","form_type":"4"}},{"id":4272471,"issuer":{"id":69639,"kind":"organization","name":"Cidara Therapeutics, Inc.","symbol":"CDTX"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-26T21:10:08.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2018 annual meeting of stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2018 annual meeting of stockholders."}],"balance_after":11000,"derivative":{"exercise_price":6.9,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-17-041858","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000120919117041858/doc4.xml","form_type":"4"}},{"id":4273382,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-23T20:07:19.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of June 21, 2018 or the date of the 2018 annual meeting of stockholders, subject to the director's continued service on the board of directors."}],"balance_after":14500,"derivative":{"exercise_price":3.95,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0000899243-17-017069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924317017069/doc4.xml","form_type":"4"}},{"id":4310938,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-22T19:05:49.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":10110,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders."}],"balance_after":10110,"derivative":{"exercise_price":19.25,"expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":10110},"source":{"system":"sec-edgar","filing":"0001179110-17-007781","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017007781/edgar.xml","form_type":"4"}},{"id":4310937,"issuer":{"id":145305,"kind":"organization","name":"AMAG PHARMACEUTICALS, INC.","symbol":"AMAG"},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-22T19:05:49.000Z","date":"2017-05-18","kind":"grant","acquired":true,"shares":4545,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the \"Issuer\"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan (the \"Plan\") that will vest in twelve equal monthly installments over one year beginning on the first day of the first full month following the Issuer's annual meeting of stockholders, however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."}],"balance_after":17535,"source":{"system":"sec-edgar","filing":"0001179110-17-007781","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/792977/000117911017007781/edgar.xml","form_type":"4"}},{"id":4448467,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":39727,"kind":"person","name":"PEREZ ROBERT J","position":1,"cik":"0001263230","reported_name":"PEREZ ROBERT J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-15T01:16:11.000Z","date":"2017-02-13","kind":"grant","acquired":true,"shares":13289,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Non-Qualified Stock Option Agreement and shall vest over a period of one year starting January 1, 2017 on a quarterly basis in arrears."}],"balance_after":13289,"derivative":{"exercise_price":4.18,"expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":13289},"source":{"system":"sec-edgar","filing":"0000899243-17-004101","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1263230/000089924317004101/doc4.xml","form_type":"4"}}]}